Barry Ticho

Recent appearances

• 

  🧬 Barry Ticho - Part 4: Founding Verve, Gene Editing Breakthroughs & Stoke’s Bold Vision

  December 05, 2024 · 📺 The Biotech Startups Podcast | Excedr

  🦠 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 ‼️ Get your unique referral link here: refer.excedr.com/ZTHETY. Part 4 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating…

  Watch on YouTube ↗

• 

  🧬 Barry Ticho - Part 3: Lessons on Drug Development & RNA's Transformative Potential

  December 02, 2024 · 📺 The Biotech Startups Podcast | Excedr

  🦠 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 ‼️ Get your unique referral link here: refer.excedr.com/ZTHETY. Part 3 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating…

  Watch on YouTube ↗

• 

  🧬 Barry Ticho - Part 2: Zebrafish Hearts & Transformative Medicine: Chasing Patient Impact

  December 01, 2024 · 📺 The Biotech Startups Podcast | Excedr

  The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 Get your unique referral link here: refer.excedr.com/ZTHETY. Part 2 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating prot…

  Watch on YouTube ↗

• 

  🧬 Barry Ticho - Part 1: From Family Medicine to Breakthrough Therapeutics

  November 25, 2024 · 📺 The Biotech Startups Podcast | Excedr

  The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success. Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸 Get your unique referral link here: refer.excedr.com/ZTHETY. Part 1 of 4: Jon Chee hosts Barry Ticho, Founder of Verve Therapeutics and Chief Medical Officer at Stoke Therapeutics, a biotech company addressing the underlying cause of severe diseases by upregulating prot…

  Watch on YouTube ↗

• 

  Working With Dravet Syndrome Advocacy Groups

  November 26, 2018 · 📺 CheckRare

  Barry Ticho, MD, Chief Medical Officer at Stoke Therapeutics, discusses how his company works with Dravet syndrome advocacy groups, including the Dravet Syndrome Foundation (DSF). DSF aggressively raises research funds for Dravet syndrome and related epilepsies. The mission of DSF is also to increase awareness of these catastrophic conditions; and to provide support to affected individuals and families. Dravet syndrome, a severe form of epilepsy that is part of a group of diseases known as SCN1A-related seizure disorders. Dravet syndrome usually appears during the first year of life as frequ…

  Watch on YouTube ↗

• 

  Stoke Therapeutics Discusses It's Technology for a Potential Therapy for Dravet Syndrome

  November 13, 2018 · 📺 CheckRare

  Barry Ticho, MD, Chief Medical Officer at Stoke Therapeutics, provides an overview the company's TANGO (Targeted Augmentation of Nuclear Gene Output) technology. TANGO allows for precisely modulating splicing to increase a target protein’s expression by exploiting naturally occurring non-productive splicing events. Stoke is planning on using this technology to bring to clinical trials a potential therapy for Dravet syndrome. Dravet syndrome, a severe form of epilepsy that is part of a group of diseases known as SCN1A-related seizure disorders. Dravet syndrome usually appears during the firs…

  Watch on YouTube ↗

• 

  Stoke Therapeutics: Working on Rare Genetic Diseases

  November 02, 2018 · 📺 CheckRare

  Barry Ticho is the Chief Medical Officer at Stoke Therapeutics, and in this clip he provides an overview of his company. Stoke Therapeutics is a biotechnology company working to increase gene expression to treat a wide array of severe genetic diseases, including genetic conditions affecting the central nervous system, eye and liver. Stoke’s lead program targets Dravet Syndrome, a rare form of genetic epilepsy that is characterized by severe and frequent seizures and cognitive impairment. By using antisense oligonucleotides to address haploinsufficiency of the sodium channel Nav 1.1., St…

  Watch on YouTube ↗

• 

  Dravet Syndrome Overview

  October 23, 2018 · 📺 CheckRare

  Barry Ticho, MD, Chief Medical Officer at Stoke Therapeutics, provides an overview of Dravet syndrome, a severe form of epilepsy that is part of a group of diseases known as SCN1A-related seizure disorders. Dravet syndrome usually appears during the first year of life as frequent fever-related (febrile) seizures. As the condition progresses, other types of seizures typically occur, including myoclonus and status epilepticus. A family history of either epilepsy or febrile seizures exists in 15% to 25% of cases. Intellectual development begins to deteriorate around age 2, and affected individu…

  Watch on YouTube ↗